SU-4029 is a reagent that interacts with α-adrenergic receptors; it reverses the blockade of norepinephrine induced by the reversible adrenergic antagonist phentolamine, but not that induced by the irreversible antagonist dibenamine; it may induce conformational changes at α-adrenergic receptor sites affected by adrenergic blockers.